MENU
IVVD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Invivyd (IVVD) Ownership - Who owns Invivyd?

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential... Show more

Profile

Industry
N/A
Address
1601 Trapelo Road
Phone
+1 781 819-0080
Employees
95
Web
https://www.invivyd.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
778.55M
P/E Ratio
N/A
Total Cash
84.97M
Projected Growth
N/A
Total Debt
2.68M
Revenue
50.04M
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash/Share
0.31
Total Debt/Equity
N/A
Revenue/Share
0.38 USD as % of share price

Fundamentals

IVVD
Capitalization
779M
P/E Ratio
N/A
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash
85M
Total Cash/Share
0.31
Total Debt
2.68M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.38%
Revenue
50M
ROE
N/A
Book Value
93.1M
P/B Ratio
8.37
Cash Flow
N/A
Earnings
-0.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
22K
Current Ratio
2.47
Current Revenue Per Employee
131290.00
Dividends Per Share - Security
N/A
EBITDA
-59.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.71
Revenue To Assets
-39.76
Shares Held By Institutions
170M
Shares Outstanding - Current
277M
Total Liabilities
46.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
534.168
View a ticker or compare two or three
IVVD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IVVD showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1601 Trapelo Road
Phone
+1 781 819-0080
Employees
95
Web
https://www.invivyd.com